Skip to Content

Join the 'TNKase' group to help and get support from people like you.

TNKase News

More Progress Needed To Get Stroke Patients Rapid Care

Posted 31 Jul 2015 by Drugs.com

FRIDAY, July 31, 2015 – Stroke victims still aren't getting treated soon enough, a new study suggests. Treating strokes quickly is critical, because the more time that elapses, the less effective stroke treatment may be, the researchers explained. A number of factors have reduced the time it takes stroke patients to get treatment. These include greater public awareness, better emergency dispatch procedures and improvements in hospital stroke units, the researchers said. But, delays in transporting stroke patients from regional hospitals to comprehensive stroke centers are still common, the team found. "Stroke requires a multi-disciplinary team that engages in a nuanced chain of events leading to treatment, and efficient and prompt patient transport via emergency medical services [EMS] is a significant link in the process," study author Dr. Michael Froehler, neurointerventionalist at ... Read more

Related support groups: Ischemic Stroke, Transient Ischemic Attack, Ischemic Stroke - Prophylaxis, Intracranial Hemorrhage, Activase, Streptokinase, TNKase, Cathflo Activase, Urokinase, Alteplase, Retavase Half-Kit, Abbokinase Open-Cath, Kabikinase, Retavase, Abbokinase, Reteplase, Streptase, Tenecteplase, Eminase, Kinlytic

Wide Variations Seen in U.S. Stroke Care

Posted 7 Jul 2015 by Drugs.com

TUESDAY, July 7, 2015 – Americans' odds of receiving a drug that can halt strokes in progress may vary widely depending on their ZIP codes, a new study finds. Experts said the findings, reported in the July issue of the journal Stroke, help verify what everyone has suspected: There are disparities in emergency stroke care across the United States, specifically in the use of a clot-busting drug called tissue plasminogen activator, or tPA. And the magnitude of the disparities was "striking," said senior researcher Dr. James Burke, of the University of Michigan in Ann Arbor. In 20 percent of hospital markets, not a single stroke patient received tPA over four years, Burke's team found. In others, up to 14 percent of stroke patients received the drug. The big question is: Why? "We really don't know what's driving this," Burke said. The hospital markets that most often gave tPA were ... Read more

Related support groups: Aspirin, Plavix, Ischemic Stroke, Clopidogrel, Transient Ischemic Attack, Effient, Aggrenox, Brilinta, Ecotrin, Ischemic Stroke - Prophylaxis, Cilostazol, Bayer Aspirin, Pletal, Thromboembolic Stroke Prophylaxis, Dipyridamole, Prasugrel, Ticagrelor, Persantine, Activase, Bufferin

Expert Tips to Detect Early Warning Signs of Stroke

Posted 11 May 2015 by Drugs.com

SUNDAY, May 10, 2015 – Prompt treatment of stroke is key to preventing death and disability, but not everyone knows how to quickly identify the early warning signs of stroke. "Today, thanks to early detection, aggressive treatment and new intervention therapies, more stroke patients than ever are returning to normal life with limited to no disability," said Dr. Stanley Tuhrim, director of the Stroke Center at Mount Sinai Hospital in New York City. "Despite these accomplishments, it is clear that there is still much more work to be done to reduce the burden of stroke in our community. The challenge remains to educate as many people as possible about stroke's earliest warning signs and symptoms, so patients can get the immediate treatment they need," he said in a hospital news release. Stroke is a leading cause of long-term disability and the fifth leading cause of death in the United ... Read more

Related support groups: Atrial Fibrillation, Ischemic Stroke, Transient Ischemic Attack, Ischemic Stroke - Prophylaxis, Cardiovascular Risk Reduction, Intracranial Hemorrhage, Cardiovascular Conditions and Disorders, Activase, Streptokinase, TNKase, Cathflo Activase, Urokinase, Alteplase, Retavase Half-Kit, Abbokinase Open-Cath, Anistreplase, Kabikinase, Retavase, Abbokinase, Streptase

Every Minute Counts for Stroke Victims, Study Confirms

Posted 18 Jun 2013 by Drugs.com

TUESDAY, June 18 – For stroke victims, 15 minutes can mean the difference between life and death, a new study finds. Rapid treatment with a clot-dissolving drug reduces stroke patients' risk of in-hospital death and increases their chances of being able to walk and return home when they leave the hospital, according to the study, published in the June 19 issue of the Journal of the American Medical Association. "These findings support intensive efforts to accelerate patient presentation and to streamline regional and hospital systems of acute stroke care to compress [onset to treatment] times," Dr. Jeffrey Saver, of the David Geffen School of Medicine at the University of California, Los Angeles, and colleagues said in a journal news release. Researchers examined data from more than 58,000 patients who suffered an ischemic stroke (in which blood flow to the brain is blocked) and were ... Read more

Related support groups: Ischemic Stroke, Activase, Streptokinase, Urokinase, TNKase, Cathflo Activase, Alteplase, Retavase Half-Kit, Abbokinase Open-Cath, Kabikinase, Reteplase, Retavase, Abbokinase, Tenecteplase, Streptase, Eminase, Anistreplase, Kinlytic

New Drug Bests Standard Treatment for Certain Strokes

Posted 21 Mar 2012 by Drugs.com

WEDNESDAY, March 21 – A new medication called tenecteplase may be more effective at treating strokes caused by clots in large blood vessels in the brain than the current standard therapy, Australian researchers report. "This study compares a newer thrombolytic medicine [tenecteplase] to the standard thrombolytic medicine [alteplase] in the treatment of patients with acute ischemic stroke," explained study author Dr. Mark Parsons, an associate professor at the University of Newcastle School of Medicine and Public Health and a senior staff specialist in neurology at John Hunter Hospital, in Newcastle. Thrombolytic drugs are essentially clot-busters. The researchers found that tenecteplase was better at restoring blood flow to the brain after a stroke than alteplase. In addition, fewer people treated with a higher dose of tenecteplase had a serious disability at 90 days after their stroke ... Read more

Related support groups: Ischemic Stroke, Activase, Cathflo Activase, TNKase, Alteplase, Tenecteplase

Ask a Question

Further Information

Related Condition Support Groups

Myocardial Infarction, Heart Attack

TNKase Patient Information at Drugs.com